Private Advisory Group’s Twist Bioscience TWST Stock Holding History

Private Advisory Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.53M	Buy	+7,934	New	+$980K	0.08%	162

Other funds holding TWST

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Private Advisory Group's TWST Position: Q3 2026 in Review

Private Advisory Group opened a new position in Twist Bioscience (TWST) in Q3 2026: 7,934 shares worth $1.53M. The stake represents 0.08% of the portfolio and ranks #162 among its holdings.

181 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

Private Advisory Group held 7,934 shares of Twist Bioscience worth $1.53M as of Q3 2026.
Twist Bioscience was a new Private Advisory Group position in Q3 2026.
Twist Bioscience made up 0.08% of Private Advisory Group's portfolio in Q3 2026, its #162 holding.
181 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Private Advisory Group's 13F filing for Q3 2026, filed 6 Nov 2026.